MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve MyelofibrosisJohn Mascarenhas, Vikas Gupta, Andrea Patriarca et al.|Journal of Clinical Oncology|2023Cited by 89